Keskin’s research focuses on vaccine immunotherapies, autoimmune diseases, and cancer immunology. He has been involved with preclinical development, such as efficacy and safety studies, in vaccine research and has more than a decade of experience in T cell-based vaccine design against cancers and viruses such as influenza, HIV, and HPV. Keskin has extensive experience planning and managing entire immunological projects, including people, study design, financials, execution, analysis, troubleshooting, and FDA/IND applications/reporting. He has been an ad hoc reviewer for journals such as Nature Cancer, Annals of Oncology, Molecular Medicine, Journal of Immunological Methods, Advances in Clinical Chemistry, Neurotoxicity Research, Journal of Investigative Dermatology, and the European Academy of Dermatology and Venereology Journal.